Lyndra Therapeutics, Inc. — Form D

Lyndra Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-23. The offering totals $65.0M, of which $60.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Robert LangerDirectorPittsburgh, PA
Catherine ReynoldsDirectorDurham, NC
Amy SchulmanDirectorCambridge, MA
Zafi S AvnurDirectorWatertown, MA
Ashish S SinghDirectorWatertown, MA
Jessica BallingerDirectorWatertown, MA
Jessica BallingerExecutive OfficerWatertown, MA
Doug S DachilleDirectorWatertown, MA
Patricia S HurterDirectorWatertown, MA
Catherine S ReynoldsDirectorWatertown, MA
Helene S MadonickDirectorWatertown, MA
Carlo Giovanni TraversoDirectorWatertown, MA
Jillian Moo-YoungDirectorWatertown, MA
Doug Giovanni DachilleDirectorWatertown, MA
Jessica Giovanni BallingerExecutive OfficerWatertown, MA
Patricia HurterDirectorWatertown, MA
Patricia HurterExecutive OfficerWatertown, MA
Zafi AvnurDirectorWatertown, MA
Catherine Giovanni ReynoldsDirectorWatertown, MA
Ashish Giovanni SinghDirectorWatertown, MA
Robert Giovanni LangerDirectorWatertown, MA
Helene Giovanni MadonickDirectorWatertown, MA
Amy W SchulmanDirectorWatertown, MA
Amy W SchulmanExecutive OfficerWatertown, MA
Robert S LangerDirectorNewton, MA

Other filings by this issuer (7)

FiledFormOfferingSold
2023-12-29D$206.1M$122.7M
2023-06-07D$179.3M$20.4M
2019-01-28D$60.9M$55.2M
2017-04-19D/A$23.1M$23.1M
2017-03-07D/A$20.1M$20.1M
2017-02-10D/A$17.1M$17.1M
2016-07-13D$5.9M$5.9M

More